The Science for Africa Foundation (SFA Foundation), nuvoteQ.io, BIO Ventures for Global Health (BVGH), Johnson & Johnson (J&J), Mérieux Foundation (FMER) and Medicines Development for Global Health Ltd (MDGH), have established the Clinical Trials Community Africa Network (CTCAN), a network for clinical research stakeholders in Africa that enables increased, sustainable, and coordinated clinical trials on the continent. The network will build on the progress of the Clinical Trials Community (CTC) platform, which was created to increase the visibility of African clinical trialists and centres while increasing clinical trial investments in Africa.
The CTCAN, supported by Global Health EDCTP3 Joint Undertaking (JU), will foster coordination in clinical research by providing a platform for all African stakeholders, including clinical researchers, regulators and industry partners to define priority diseases for clinical research. The network will also raise awareness of the existing capacity of centres and laboratories across Africa, contribute to the operationalisation and harmonisation of regulatory processes across the region, and strengthen less experienced centres and labs through a clinical trial preparedness framework while encouraging inter- and cross continental knowledge- and expertise-sharing.